.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Fuji
Citi
Queensland Health
QuintilesIMS
Express Scripts
Chinese Patent Office
Argus Health
Teva
Farmers Insurance

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 065214

« Back to Dashboard

NDA 065214 describes CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER, which is a drug marketed by B Braun and is included in one NDA. It is available from one supplier. Additional details are available on the CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER profile page.

The generic ingredient in CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER is cefoxitin sodium. There are eight drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the cefoxitin sodium profile page.

Summary for 065214

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 065214

Ingredient-typeCephalosporins

Medical Subject Heading (MeSH) Categories for 065214

Suppliers and Packaging for NDA: 065214

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER cefoxitin sodium INJECTABLE;INJECTION 065214 NDA B. Braun Medical Inc. 0264-3123 0264-3123-11 24 CONTAINER in 1 CASE (0264-3123-11) > 50 mL in 1 CONTAINER
CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER cefoxitin sodium INJECTABLE;INJECTION 065214 NDA B. Braun Medical Inc. 0264-3125 0264-3125-11 24 CONTAINER in 1 CASE (0264-3125-11) > 50 mL in 1 CONTAINER

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 1GM BASE/VIAL
Approval Date:Mar 10, 2006TE:APRLD:Yes

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 2GM BASE/VIAL
Approval Date:Mar 10, 2006TE:APRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Novartis
Healthtrust
US Army
McKinsey
AstraZeneca
Citi
Covington
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot